Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA)
Ragini Shivji, Roberto Conocchia, Evdokia Korakianiti, Veronika Jekerle
Topics & Concepts
InterimAgency (philosophy)BusinessCoronavirus disease 2019 (COVID-19)Quality (philosophy)Flexibility (engineering)Regulatory affairsPandemicGood manufacturing practiceProcess managementMedicineEngineeringPolitical scienceSupply chainMarketingOperations managementManagementInfectious disease (medical specialty)EconomicsDiseaseEpistemologyLawPathologyPhilosophyBiosimilars and Bioanalytical MethodsPharmaceutical Economics and PolicyPharmacovigilance and Adverse Drug Reactions